港股稀缺性资产受市场关注，港股通医疗ETF今日重磅上市

Market Performance - The Hang Seng Index rose by 0.52% to 25,041.03 points, while the Hang Seng Tech Index increased by 0.54% and the Hang Seng China Enterprises Index strengthened by 0.36% with a half-day trading volume of HKD 141.77 billion [1] Investment Trends - Since the beginning of the year, the Hong Kong stock market has shown a more significant increase compared to the A-share market, with highlights in innovative pharmaceuticals, new consumption, and AI applications [1] - Despite a relatively volatile market since late June, Hong Kong tech stocks have underperformed compared to innovative pharmaceuticals [1] Economic Context - China is at a critical juncture of transitioning from old to new economic drivers, facing challenges in macroeconomic growth, leading to asset scarcity pressures for domestic funds [1] - Similar to the period of 2012-2014, while there is a lack of upward momentum at the macro level, profound changes are occurring at the industrial level, such as shifts in consumption structure and the emergence of a new upward cycle driven by AI technology [1] New Investment Products - The Hong Kong Stock Connect Medical ETF (520510) was launched on the Shanghai Stock Exchange, enabling T+0 trading and filling a gap in the Hong Kong Stock Connect medical sector, providing investors with more options in CXO, innovative pharmaceuticals, and AI healthcare [1]